Bad Heilbrunn, Germany

Christina Rabe

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Roche Diagnostics Operations, Inc.. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christina Rabe: Innovator in Predictive Medicine

Introduction

Christina Rabe is a notable inventor based in Bad Heilbrunn, Germany. She has made significant contributions to the field of predictive medicine, particularly in the area of acute kidney injury (AKI) risk assessment. Her innovative work has the potential to improve patient outcomes during surgical procedures.

Latest Patents

Christina Rabe holds a patent for her invention titled "IGFBP7 for prediction of risk of AKI when measured prior to surgery." This patent describes a method for predicting the risk of a patient suffering from acute kidney injury during or after surgical procedures or after the administration of contrast media. The method relies on determining the level of the biomarker IGFBP7 (Insulin-like Growth Factor Binding Protein 7) in a body fluid sample obtained from the patient prior to the surgical procedure. Additionally, the patent outlines a method that also considers the biomarker Cystatin C to enhance the predictive capability. The disclosure further includes kits and devices designed to implement these methods effectively.

Career Highlights

Throughout her career, Christina Rabe has worked with prominent companies in the healthcare sector, including Roche Diagnostics Operations, Inc. and Roche Diagnostics GmbH. Her experience in these organizations has allowed her to develop and refine her innovative ideas in medical diagnostics.

Collaborations

Christina has collaborated with esteemed colleagues such as Andrea Horsch and Birgit Klapperich. These partnerships have contributed to her success and the advancement of her research in predictive medicine.

Conclusion

Christina Rabe's work in the field of predictive medicine, particularly her patent on IGFBP7, showcases her commitment to improving patient care through innovation. Her contributions are paving the way for advancements in the prediction and prevention of acute kidney injury.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…